instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Burkholderia cepacia complex infection'. | Clinico-microbiological profile of Burkholderia cepacia keratitis: a case series.
BACKGROUND
Burkholderia cepacia, an opportunistic pathogen mainly affecting patients with cystic fibrosis or immunocompromised, has rarely been documented as a cause of corneal infection. The clinical and microbiological profiles of B. ce... | ACYCLOVIR, PREDNISOLONE ACETATE | DrugsGivenReaction | CC BY | 33413453 | 18,876,037 | 2021-01-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Keratitis bacterial'. | Clinico-microbiological profile of Burkholderia cepacia keratitis: a case series.
BACKGROUND
Burkholderia cepacia, an opportunistic pathogen mainly affecting patients with cystic fibrosis or immunocompromised, has rarely been documented as a cause of corneal infection. The clinical and microbiological profiles of B. ce... | ACYCLOVIR, PREDNISOLONE ACETATE | DrugsGivenReaction | CC BY | 33413453 | 18,876,037 | 2021-01-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic response decreased'. | Clinico-microbiological profile of Burkholderia cepacia keratitis: a case series.
BACKGROUND
Burkholderia cepacia, an opportunistic pathogen mainly affecting patients with cystic fibrosis or immunocompromised, has rarely been documented as a cause of corneal infection. The clinical and microbiological profiles of B. ce... | CEFTAZIDIME, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 33413453 | 18,936,160 | 2021-01-07 |
What was the administration route of drug 'ACYCLOVIR'? | Clinico-microbiological profile of Burkholderia cepacia keratitis: a case series.
BACKGROUND
Burkholderia cepacia, an opportunistic pathogen mainly affecting patients with cystic fibrosis or immunocompromised, has rarely been documented as a cause of corneal infection. The clinical and microbiological profiles of B. ce... | Oral | DrugAdministrationRoute | CC BY | 33413453 | 18,876,037 | 2021-01-07 |
What was the administration route of drug 'PREDNISOLONE ACETATE'? | Clinico-microbiological profile of Burkholderia cepacia keratitis: a case series.
BACKGROUND
Burkholderia cepacia, an opportunistic pathogen mainly affecting patients with cystic fibrosis or immunocompromised, has rarely been documented as a cause of corneal infection. The clinical and microbiological profiles of B. ce... | Topical | DrugAdministrationRoute | CC BY | 33413453 | 18,876,037 | 2021-01-07 |
What was the outcome of reaction 'Burkholderia cepacia complex infection'? | Clinico-microbiological profile of Burkholderia cepacia keratitis: a case series.
BACKGROUND
Burkholderia cepacia, an opportunistic pathogen mainly affecting patients with cystic fibrosis or immunocompromised, has rarely been documented as a cause of corneal infection. The clinical and microbiological profiles of B. ce... | Recovered with sequelae (consequent health issues) | ReactionOutcome | CC BY | 33413453 | 18,876,037 | 2021-01-07 |
What was the outcome of reaction 'Keratitis bacterial'? | Clinico-microbiological profile of Burkholderia cepacia keratitis: a case series.
BACKGROUND
Burkholderia cepacia, an opportunistic pathogen mainly affecting patients with cystic fibrosis or immunocompromised, has rarely been documented as a cause of corneal infection. The clinical and microbiological profiles of B. ce... | Recovered with sequelae (consequent health issues) | ReactionOutcome | CC BY | 33413453 | 18,876,037 | 2021-01-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | HUMAN IMMUNOGLOBULIN G, INFLIXIMAB, METHYLPREDNISOLONE, PREDNISONE | DrugsGivenReaction | CC BY-NC | 33414264 | 18,750,143 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia parainfluenzae viral'. | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | ALBUTEROL\IPRATROPIUM, AZTREONAM, CHLORHEXIDINE, ENOXAPARIN, FLUOXETINE HYDROCHLORIDE, INFLIXIMAB, INSULIN ASPART, LEVOTHYROXINE, METHYLPREDNISOLONE SODIUM SUCCINATE, MIDAZOLAM, MOXIFLOXACIN, PANTOPRAZOLE, PREDNISONE, PREGABALIN, SULFAMETHOXAZOLE\TRIMETHOPRIM, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonitis'. | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | HUMAN IMMUNOGLOBULIN G, INFLIXIMAB, METHYLPREDNISOLONE, PREDNISONE | DrugsGivenReaction | CC BY-NC | 33414264 | 18,750,143 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory tract infection'. | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | ALBUTEROL\IPRATROPIUM, AZTREONAM, CHLORHEXIDINE, ENOXAPARIN, FLUOXETINE HYDROCHLORIDE, INFLIXIMAB, INSULIN ASPART, LEVOTHYROXINE, METHYLPREDNISOLONE SODIUM SUCCINATE, MIDAZOLAM, MOXIFLOXACIN, PANTOPRAZOLE, PREDNISONE, PREGABALIN, SULFAMETHOXAZOLE\TRIMETHOPRIM, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the administration route of drug 'AZTREONAM'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the administration route of drug 'ENOXAPARIN'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the administration route of drug 'FLUOXETINE HYDROCHLORIDE'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Oral | DrugAdministrationRoute | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33414264 | 18,842,724 | 2021-01 |
What was the administration route of drug 'INFLIXIMAB'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the administration route of drug 'INSULIN ASPART'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the administration route of drug 'LEVOTHYROXINE'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the administration route of drug 'MOXIFLOXACIN'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the administration route of drug 'PANTOPRAZOLE'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Oral | DrugAdministrationRoute | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the administration route of drug 'PREGABALIN'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Oral | DrugAdministrationRoute | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the administration route of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Oral | DrugAdministrationRoute | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the administration route of drug 'VANCOMYCIN'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the dosage of drug 'ALBUTEROL\IPRATROPIUM'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | 3 ML (NEBULIZATION) Q6HR | DrugDosageText | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the dosage of drug 'AZTREONAM'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | 2 G, Q8HR | DrugDosageText | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the dosage of drug 'CHLORHEXIDINE'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | 15 ML, Q12H (MOUTH/THROAT) | DrugDosageText | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the dosage of drug 'ENOXAPARIN'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | 40 MG, BID | DrugDosageText | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the dosage of drug 'FLUOXETINE HYDROCHLORIDE'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | 40 MG, DAILY | DrugDosageText | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the dosage of drug 'INSULIN ASPART'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | 0?6 UNITS, TID DURING MEALS | DrugDosageText | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the dosage of drug 'LEVOTHYROXINE'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | 38 MCG, DAILY | DrugDosageText | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the dosage of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | 60 MG, BID | DrugDosageText | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the dosage of drug 'MIDAZOLAM'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | 5 MG/HR | DrugDosageText | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the dosage of drug 'MOXIFLOXACIN'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | 400 MG, Q24H | DrugDosageText | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the dosage of drug 'PANTOPRAZOLE'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | 40 MG, DAILY | DrugDosageText | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the dosage of drug 'PREGABALIN'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | 50 MG, BID | DrugDosageText | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the dosage of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | 1 TABLET, ONCE PER DAY ON MON WED FRI | DrugDosageText | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the dosage of drug 'VANCOMYCIN'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | 15 MG/KG/DOSE, Q12H | DrugDosageText | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the outcome of reaction 'Condition aggravated'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Fatal | ReactionOutcome | CC BY-NC | 33414264 | 18,750,143 | 2021-01 |
What was the outcome of reaction 'Drug ineffective for unapproved indication'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Fatal | ReactionOutcome | CC BY-NC | 33414264 | 18,842,724 | 2021-01 |
What was the outcome of reaction 'Immune-mediated pneumonitis'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Fatal | ReactionOutcome | CC BY-NC | 33414264 | 18,842,724 | 2021-01 |
What was the outcome of reaction 'Off label use'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Fatal | ReactionOutcome | CC BY-NC | 33414264 | 18,842,724 | 2021-01 |
What was the outcome of reaction 'Pneumonia parainfluenzae viral'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Fatal | ReactionOutcome | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
What was the outcome of reaction 'Pneumonitis'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Fatal | ReactionOutcome | CC BY-NC | 33414264 | 18,750,143 | 2021-01 |
What was the outcome of reaction 'Respiratory tract infection'? | Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes.
Immune-checkpoint inhibitor (ICI)-pneumonitis that does not improve or resolve with corticosteroids and requires additional immunosuppression is termed steroid-refractory ICI-pneumonitis. Herein, we report the clinical featur... | Fatal | ReactionOutcome | CC BY-NC | 33414264 | 18,750,080 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Jejunal ulcer'. | Small intestinal thrombotic microangiopathy following kidney transplantation diagnosed by balloon-assisted enteroscopy.
Thrombotic microangiopathy (TMA) is a serious complication following kidney transplantation. Although intestinal TMA is a major organ injury and causes abdominal pain, diarrhea and bloody stools, the ... | EVEROLIMUS, METHYLPREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-SA | 33414631 | 18,901,717 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Small intestinal stenosis'. | Small intestinal thrombotic microangiopathy following kidney transplantation diagnosed by balloon-assisted enteroscopy.
Thrombotic microangiopathy (TMA) is a serious complication following kidney transplantation. Although intestinal TMA is a major organ injury and causes abdominal pain, diarrhea and bloody stools, the ... | EVEROLIMUS, METHYLPREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-SA | 33414631 | 18,901,717 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombotic microangiopathy'. | Small intestinal thrombotic microangiopathy following kidney transplantation diagnosed by balloon-assisted enteroscopy.
Thrombotic microangiopathy (TMA) is a serious complication following kidney transplantation. Although intestinal TMA is a major organ injury and causes abdominal pain, diarrhea and bloody stools, the ... | EVEROLIMUS, METHYLPREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-SA | 33414631 | 18,901,717 | 2021 |
What was the outcome of reaction 'Jejunal ulcer'? | Small intestinal thrombotic microangiopathy following kidney transplantation diagnosed by balloon-assisted enteroscopy.
Thrombotic microangiopathy (TMA) is a serious complication following kidney transplantation. Although intestinal TMA is a major organ injury and causes abdominal pain, diarrhea and bloody stools, the ... | Recovering | ReactionOutcome | CC BY-NC-SA | 33414631 | 18,901,717 | 2021 |
What was the outcome of reaction 'Thrombotic microangiopathy'? | Small intestinal thrombotic microangiopathy following kidney transplantation diagnosed by balloon-assisted enteroscopy.
Thrombotic microangiopathy (TMA) is a serious complication following kidney transplantation. Although intestinal TMA is a major organ injury and causes abdominal pain, diarrhea and bloody stools, the ... | Recovering | ReactionOutcome | CC BY-NC-SA | 33414631 | 18,901,717 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematemesis'. | Regorafenib-induced exacerbation of chronic immune thrombocytopenic purpura in remission: A case report.
Regorafenib is an oral multi-kinase inhibitor which targets tumor angiogenesis, the tumor microenvironment and oncogenesis. Based on this mode of action, regorafenib has a broad spectrum of toxicities. However, at p... | REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33414911 | 18,800,829 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune thrombocytopenia'. | Regorafenib-induced exacerbation of chronic immune thrombocytopenic purpura in remission: A case report.
Regorafenib is an oral multi-kinase inhibitor which targets tumor angiogenesis, the tumor microenvironment and oncogenesis. Based on this mode of action, regorafenib has a broad spectrum of toxicities. However, at p... | REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33414911 | 18,800,829 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Regorafenib-induced exacerbation of chronic immune thrombocytopenic purpura in remission: A case report.
Regorafenib is an oral multi-kinase inhibitor which targets tumor angiogenesis, the tumor microenvironment and oncogenesis. Based on this mode of action, regorafenib has a broad spectrum of toxicities. However, at p... | REGORAFENIB | DrugsGivenReaction | CC BY-NC-ND | 33414911 | 18,800,829 | 2021-02 |
What was the administration route of drug 'REGORAFENIB'? | Regorafenib-induced exacerbation of chronic immune thrombocytopenic purpura in remission: A case report.
Regorafenib is an oral multi-kinase inhibitor which targets tumor angiogenesis, the tumor microenvironment and oncogenesis. Based on this mode of action, regorafenib has a broad spectrum of toxicities. However, at p... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33414911 | 18,800,829 | 2021-02 |
What was the outcome of reaction 'Haematemesis'? | Regorafenib-induced exacerbation of chronic immune thrombocytopenic purpura in remission: A case report.
Regorafenib is an oral multi-kinase inhibitor which targets tumor angiogenesis, the tumor microenvironment and oncogenesis. Based on this mode of action, regorafenib has a broad spectrum of toxicities. However, at p... | Recovered | ReactionOutcome | CC BY-NC-ND | 33414911 | 18,800,829 | 2021-02 |
What was the outcome of reaction 'Immune thrombocytopenia'? | Regorafenib-induced exacerbation of chronic immune thrombocytopenic purpura in remission: A case report.
Regorafenib is an oral multi-kinase inhibitor which targets tumor angiogenesis, the tumor microenvironment and oncogenesis. Based on this mode of action, regorafenib has a broad spectrum of toxicities. However, at p... | Recovered | ReactionOutcome | CC BY-NC-ND | 33414911 | 18,800,829 | 2021-02 |
What was the outcome of reaction 'Thrombocytopenia'? | Regorafenib-induced exacerbation of chronic immune thrombocytopenic purpura in remission: A case report.
Regorafenib is an oral multi-kinase inhibitor which targets tumor angiogenesis, the tumor microenvironment and oncogenesis. Based on this mode of action, regorafenib has a broad spectrum of toxicities. However, at p... | Recovered | ReactionOutcome | CC BY-NC-ND | 33414911 | 18,800,829 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection.
Acute kidney injury (AKI) associated with severe coronavirus disease 19 (COVID-19) is common and is a significant predictor of morbidity and mortality, especially when dialysis is required. Case reports and autopsy series have revealed that mo... | ACYCLOVIR, AMIODARONE, AMOXICILLIN\CLAVULANIC ACID, ATORVASTATIN, DAPTOMYCIN, HYDROXYCHLOROQUINE, IMIPENEM, MEROPENEM, PANTOPRAZOLE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, PREDNISOLONE, TIGECYCLINE, VANCOMYCIN, VORICONAZOLE | DrugsGivenReaction | CC BY | 33419393 | 18,857,967 | 2021-01-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrial fibrillation'. | Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection.
Acute kidney injury (AKI) associated with severe coronavirus disease 19 (COVID-19) is common and is a significant predictor of morbidity and mortality, especially when dialysis is required. Case reports and autopsy series have revealed that mo... | ACYCLOVIR, AMIODARONE, AMOXICILLIN\CLAVULANIC ACID, ATORVASTATIN, DAPTOMYCIN, HYDROXYCHLOROQUINE, IMIPENEM, MEROPENEM, PANTOPRAZOLE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, PREDNISOLONE, TIGECYCLINE, VANCOMYCIN, VORICONAZOLE | DrugsGivenReaction | CC BY | 33419393 | 18,857,967 | 2021-01-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic kidney disease'. | Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection.
Acute kidney injury (AKI) associated with severe coronavirus disease 19 (COVID-19) is common and is a significant predictor of morbidity and mortality, especially when dialysis is required. Case reports and autopsy series have revealed that mo... | ACYCLOVIR, AMIODARONE, AMOXICILLIN\CLAVULANIC ACID, ATORVASTATIN, DAPTOMYCIN, HYDROXYCHLOROQUINE, IMIPENEM, MEROPENEM, PANTOPRAZOLE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, TIGECYCLINE, VANCOMYCIN, VORICONAZOLE | DrugsGivenReaction | CC BY | 33419393 | 18,855,984 | 2021-01-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ileus paralytic'. | Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection.
Acute kidney injury (AKI) associated with severe coronavirus disease 19 (COVID-19) is common and is a significant predictor of morbidity and mortality, especially when dialysis is required. Case reports and autopsy series have revealed that mo... | ACYCLOVIR, AMIODARONE, AMOXICILLIN\CLAVULANIC ACID, ATORVASTATIN, DAPTOMYCIN, HYDROXYCHLOROQUINE, IMIPENEM, MEROPENEM, PANTOPRAZOLE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, PREDNISOLONE, TIGECYCLINE, VANCOMYCIN, VORICONAZOLE | DrugsGivenReaction | CC BY | 33419393 | 18,857,967 | 2021-01-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metabolic acidosis'. | Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection.
Acute kidney injury (AKI) associated with severe coronavirus disease 19 (COVID-19) is common and is a significant predictor of morbidity and mortality, especially when dialysis is required. Case reports and autopsy series have revealed that mo... | ACYCLOVIR, AMIODARONE, AMOXICILLIN\CLAVULANIC ACID, ATORVASTATIN, DAPTOMYCIN, HYDROXYCHLOROQUINE, IMIPENEM, MEROPENEM, PANTOPRAZOLE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, TIGECYCLINE, VANCOMYCIN, VORICONAZOLE | DrugsGivenReaction | CC BY | 33419393 | 18,855,984 | 2021-01-08 |
What was the dosage of drug 'DAPTOMYCIN'? | Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection.
Acute kidney injury (AKI) associated with severe coronavirus disease 19 (COVID-19) is common and is a significant predictor of morbidity and mortality, especially when dialysis is required. Case reports and autopsy series have revealed that mo... | 40 mg (milligrams). | DrugDosage | CC BY | 33419393 | 18,857,967 | 2021-01-08 |
What was the dosage of drug 'VANCOMYCIN'? | Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection.
Acute kidney injury (AKI) associated with severe coronavirus disease 19 (COVID-19) is common and is a significant predictor of morbidity and mortality, especially when dialysis is required. Case reports and autopsy series have revealed that mo... | 40 mg (milligrams). | DrugDosage | CC BY | 33419393 | 18,857,967 | 2021-01-08 |
What was the outcome of reaction 'Acute kidney injury'? | Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection.
Acute kidney injury (AKI) associated with severe coronavirus disease 19 (COVID-19) is common and is a significant predictor of morbidity and mortality, especially when dialysis is required. Case reports and autopsy series have revealed that mo... | Recovering | ReactionOutcome | CC BY | 33419393 | 18,857,967 | 2021-01-08 |
What was the outcome of reaction 'Haemolytic anaemia'? | Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection.
Acute kidney injury (AKI) associated with severe coronavirus disease 19 (COVID-19) is common and is a significant predictor of morbidity and mortality, especially when dialysis is required. Case reports and autopsy series have revealed that mo... | Recovering | ReactionOutcome | CC BY | 33419393 | 18,855,984 | 2021-01-08 |
What was the outcome of reaction 'Metabolic acidosis'? | Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection.
Acute kidney injury (AKI) associated with severe coronavirus disease 19 (COVID-19) is common and is a significant predictor of morbidity and mortality, especially when dialysis is required. Case reports and autopsy series have revealed that mo... | Recovering | ReactionOutcome | CC BY | 33419393 | 18,855,984 | 2021-01-08 |
What was the outcome of reaction 'Rash maculo-papular'? | Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection.
Acute kidney injury (AKI) associated with severe coronavirus disease 19 (COVID-19) is common and is a significant predictor of morbidity and mortality, especially when dialysis is required. Case reports and autopsy series have revealed that mo... | Recovering | ReactionOutcome | CC BY | 33419393 | 18,855,984 | 2021-01-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain'. | Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients.
BACKGROUND
Hyperthermic intraperitoneal chemotherapy (HIPEC) is an important treatment for ovarian cancer. A certain portion of cisplatin exits the body via the perfusate at the end of... | CISPLATIN | DrugsGivenReaction | CC BY | 33419462 | 18,778,172 | 2021-01-08 |
What was the dosage of drug 'CISPLATIN'? | Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients.
BACKGROUND
Hyperthermic intraperitoneal chemotherapy (HIPEC) is an important treatment for ovarian cancer. A certain portion of cisplatin exits the body via the perfusate at the end of... | 43 DEGREE C FOR 90 MIN | DrugDosageText | CC BY | 33419462 | 18,778,172 | 2021-01-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Flucloxacillin and paracetamol induced pyroglutamic acidosis.
A 75-year-old woman was admitted to a regional hospital with an acute kidney injury (AKI) and nausea on a background of recent treatment for Staphylococcus aureus bacteraemia secondary to pneumonia. The treatment thereof resulted in a high anion gap metaboli... | ACETAMINOPHEN, ACETAMINOPHEN\CODEINE PHOSPHATE\DOXYLAMINE SUCCINATE, ALBUTEROL, ASPIRIN, CHOLECALCIFEROL, DENOSUMAB, DOCUSATE, DOXYLAMINE, DULOXETINE, FLUCLOXACILLIN, HYDROMORPHONE, HYDROXOCOBALAMIN, PANTOPRAZOLE, POLYETHYLENE GLYCOLS, PREDNISOLONE, TOPIRAMATE | DrugsGivenReaction | CC BY-NC | 33419747 | 18,849,246 | 2021-01-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Flucloxacillin and paracetamol induced pyroglutamic acidosis.
A 75-year-old woman was admitted to a regional hospital with an acute kidney injury (AKI) and nausea on a background of recent treatment for Staphylococcus aureus bacteraemia secondary to pneumonia. The treatment thereof resulted in a high anion gap metaboli... | ACETAMINOPHEN\HYDROCODONE, FLUCLOXACILLIN, GENTAMICIN | DrugsGivenReaction | CC BY-NC | 33419747 | 15,450,932 | 2021-01-08 |
What was the administration route of drug 'FLUCLOXACILLIN'? | Flucloxacillin and paracetamol induced pyroglutamic acidosis.
A 75-year-old woman was admitted to a regional hospital with an acute kidney injury (AKI) and nausea on a background of recent treatment for Staphylococcus aureus bacteraemia secondary to pneumonia. The treatment thereof resulted in a high anion gap metaboli... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33419747 | 18,962,864 | 2021-01-08 |
What was the dosage of drug 'ACETAMINOPHEN\HYDROCODONE'? | Flucloxacillin and paracetamol induced pyroglutamic acidosis.
A 75-year-old woman was admitted to a regional hospital with an acute kidney injury (AKI) and nausea on a background of recent treatment for Staphylococcus aureus bacteraemia secondary to pneumonia. The treatment thereof resulted in a high anion gap metaboli... | UNKNOWN | DrugDosageText | CC BY-NC | 33419747 | 15,450,932 | 2021-01-08 |
What was the dosage of drug 'GENTAMICIN'? | Flucloxacillin and paracetamol induced pyroglutamic acidosis.
A 75-year-old woman was admitted to a regional hospital with an acute kidney injury (AKI) and nausea on a background of recent treatment for Staphylococcus aureus bacteraemia secondary to pneumonia. The treatment thereof resulted in a high anion gap metaboli... | UNKNOWN | DrugDosageText | CC BY-NC | 33419747 | 15,450,932 | 2021-01-08 |
What was the outcome of reaction 'Acute kidney injury'? | Flucloxacillin and paracetamol induced pyroglutamic acidosis.
A 75-year-old woman was admitted to a regional hospital with an acute kidney injury (AKI) and nausea on a background of recent treatment for Staphylococcus aureus bacteraemia secondary to pneumonia. The treatment thereof resulted in a high anion gap metaboli... | Recovered | ReactionOutcome | CC BY-NC | 33419747 | 18,849,246 | 2021-01-08 |
What was the outcome of reaction 'Metabolic acidosis'? | Flucloxacillin and paracetamol induced pyroglutamic acidosis.
A 75-year-old woman was admitted to a regional hospital with an acute kidney injury (AKI) and nausea on a background of recent treatment for Staphylococcus aureus bacteraemia secondary to pneumonia. The treatment thereof resulted in a high anion gap metaboli... | Recovered | ReactionOutcome | CC BY-NC | 33419747 | 18,849,246 | 2021-01-08 |
What was the outcome of reaction 'Pyroglutamic acidosis'? | Flucloxacillin and paracetamol induced pyroglutamic acidosis.
A 75-year-old woman was admitted to a regional hospital with an acute kidney injury (AKI) and nausea on a background of recent treatment for Staphylococcus aureus bacteraemia secondary to pneumonia. The treatment thereof resulted in a high anion gap metaboli... | Recovered | ReactionOutcome | CC BY-NC | 33419747 | 18,962,864 | 2021-01-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cholecystitis acute'. | A Case of Hemorrhagic Cholecystitis and Hemobilia Under Anticoagulation Therapy.
BACKGROUND Hemorrhagic cholecystitis is a rare disease which can be fatal in some cases. Hemorrhagic cholecystitis can sometimes be confused with common biliary diagnoses, as its symptoms imitate other hepatobiliary diseases. We report a c... | ASPIRIN, CLOPIDOGREL BISULFATE, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 33419958 | 19,412,273 | 2021-01-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemobilia'. | A Case of Hemorrhagic Cholecystitis and Hemobilia Under Anticoagulation Therapy.
BACKGROUND Hemorrhagic cholecystitis is a rare disease which can be fatal in some cases. Hemorrhagic cholecystitis can sometimes be confused with common biliary diagnoses, as its symptoms imitate other hepatobiliary diseases. We report a c... | ASPIRIN, CLOPIDOGREL BISULFATE, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 33419958 | 19,412,273 | 2021-01-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhagic ascites'. | A Case of Hemorrhagic Cholecystitis and Hemobilia Under Anticoagulation Therapy.
BACKGROUND Hemorrhagic cholecystitis is a rare disease which can be fatal in some cases. Hemorrhagic cholecystitis can sometimes be confused with common biliary diagnoses, as its symptoms imitate other hepatobiliary diseases. We report a c... | ASPIRIN, CLOPIDOGREL BISULFATE, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 33419958 | 19,399,124 | 2021-01-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhagic cholecystitis'. | A Case of Hemorrhagic Cholecystitis and Hemobilia Under Anticoagulation Therapy.
BACKGROUND Hemorrhagic cholecystitis is a rare disease which can be fatal in some cases. Hemorrhagic cholecystitis can sometimes be confused with common biliary diagnoses, as its symptoms imitate other hepatobiliary diseases. We report a c... | ASPIRIN, CLOPIDOGREL BISULFATE, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 33419958 | 19,399,124 | 2021-01-09 |
What was the administration route of drug 'ASPIRIN'? | A Case of Hemorrhagic Cholecystitis and Hemobilia Under Anticoagulation Therapy.
BACKGROUND Hemorrhagic cholecystitis is a rare disease which can be fatal in some cases. Hemorrhagic cholecystitis can sometimes be confused with common biliary diagnoses, as its symptoms imitate other hepatobiliary diseases. We report a c... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33419958 | 19,399,124 | 2021-01-09 |
What was the administration route of drug 'CLOPIDOGREL BISULFATE'? | A Case of Hemorrhagic Cholecystitis and Hemobilia Under Anticoagulation Therapy.
BACKGROUND Hemorrhagic cholecystitis is a rare disease which can be fatal in some cases. Hemorrhagic cholecystitis can sometimes be confused with common biliary diagnoses, as its symptoms imitate other hepatobiliary diseases. We report a c... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33419958 | 19,399,124 | 2021-01-09 |
What was the administration route of drug 'WARFARIN'? | A Case of Hemorrhagic Cholecystitis and Hemobilia Under Anticoagulation Therapy.
BACKGROUND Hemorrhagic cholecystitis is a rare disease which can be fatal in some cases. Hemorrhagic cholecystitis can sometimes be confused with common biliary diagnoses, as its symptoms imitate other hepatobiliary diseases. We report a c... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33419958 | 19,399,124 | 2021-01-09 |
What was the dosage of drug 'ASPIRIN'? | A Case of Hemorrhagic Cholecystitis and Hemobilia Under Anticoagulation Therapy.
BACKGROUND Hemorrhagic cholecystitis is a rare disease which can be fatal in some cases. Hemorrhagic cholecystitis can sometimes be confused with common biliary diagnoses, as its symptoms imitate other hepatobiliary diseases. We report a c... | 100 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33419958 | 19,399,124 | 2021-01-09 |
What was the dosage of drug 'WARFARIN'? | A Case of Hemorrhagic Cholecystitis and Hemobilia Under Anticoagulation Therapy.
BACKGROUND Hemorrhagic cholecystitis is a rare disease which can be fatal in some cases. Hemorrhagic cholecystitis can sometimes be confused with common biliary diagnoses, as its symptoms imitate other hepatobiliary diseases. We report a c... | 3 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33419958 | 19,399,124 | 2021-01-09 |
What was the outcome of reaction 'Cholecystitis acute'? | A Case of Hemorrhagic Cholecystitis and Hemobilia Under Anticoagulation Therapy.
BACKGROUND Hemorrhagic cholecystitis is a rare disease which can be fatal in some cases. Hemorrhagic cholecystitis can sometimes be confused with common biliary diagnoses, as its symptoms imitate other hepatobiliary diseases. We report a c... | Recovered | ReactionOutcome | CC BY-NC-ND | 33419958 | 19,412,273 | 2021-01-09 |
What was the outcome of reaction 'Haemobilia'? | A Case of Hemorrhagic Cholecystitis and Hemobilia Under Anticoagulation Therapy.
BACKGROUND Hemorrhagic cholecystitis is a rare disease which can be fatal in some cases. Hemorrhagic cholecystitis can sometimes be confused with common biliary diagnoses, as its symptoms imitate other hepatobiliary diseases. We report a c... | Recovered | ReactionOutcome | CC BY-NC-ND | 33419958 | 19,412,273 | 2021-01-09 |
What was the outcome of reaction 'Haemorrhagic ascites'? | A Case of Hemorrhagic Cholecystitis and Hemobilia Under Anticoagulation Therapy.
BACKGROUND Hemorrhagic cholecystitis is a rare disease which can be fatal in some cases. Hemorrhagic cholecystitis can sometimes be confused with common biliary diagnoses, as its symptoms imitate other hepatobiliary diseases. We report a c... | Recovered | ReactionOutcome | CC BY-NC-ND | 33419958 | 19,399,124 | 2021-01-09 |
What was the outcome of reaction 'Haemorrhagic cholecystitis'? | A Case of Hemorrhagic Cholecystitis and Hemobilia Under Anticoagulation Therapy.
BACKGROUND Hemorrhagic cholecystitis is a rare disease which can be fatal in some cases. Hemorrhagic cholecystitis can sometimes be confused with common biliary diagnoses, as its symptoms imitate other hepatobiliary diseases. We report a c... | Recovered | ReactionOutcome | CC BY-NC-ND | 33419958 | 19,399,124 | 2021-01-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaphylactic reaction'. | Drug-induced anaphylaxis during general anesthesia in 14 tertiary hospitals in Japan: a retrospective, multicenter, observational study.
Since perioperative anaphylaxis occurs suddenly, and it can be life-threatening, anesthesiologists need to have sufficient knowledge of the epidemiology of perioperative anaphylaxis a... | LIDOCAINE | DrugsGivenReaction | CC BY | 33420820 | 19,246,162 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Differentiation syndrome'. | The impact of ICAM-1, CCL2 and TGM2 gene polymorphisms on differentiation syndrome in acute promyelocytic leukemia.
BACKGROUND
Although arsenic trioxide (ATO) and all-trans retinoic acid (ATRA) are well-tolerated and effective treatments for Acute Promyelocytic Leukemia (APL), Differentiation Syndrome (DS) is a lethal ... | ARSENIC TRIOXIDE, TRETINOIN | DrugsGivenReaction | CC BY | 33422029 | 19,136,194 | 2021-01-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Adapting MRI as a clinical outcome measure for a facioscapulohumeral muscular dystrophy trial of prednisone and tacrolimus: case report.
BACKGROUND
Facioscapulohumeral muscular dystrophy (FSHD) is a patchy and slowly progressive disease of skeletal muscle. MRI short tau inversion recovery (STIR) sequences of patient mu... | PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 33422031 | 18,990,465 | 2021-01-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Adapting MRI as a clinical outcome measure for a facioscapulohumeral muscular dystrophy trial of prednisone and tacrolimus: case report.
BACKGROUND
Facioscapulohumeral muscular dystrophy (FSHD) is a patchy and slowly progressive disease of skeletal muscle. MRI short tau inversion recovery (STIR) sequences of patient mu... | PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY | 33422031 | 19,059,262 | 2021-01-09 |
What is the weight of the patient? | Adapting MRI as a clinical outcome measure for a facioscapulohumeral muscular dystrophy trial of prednisone and tacrolimus: case report.
BACKGROUND
Facioscapulohumeral muscular dystrophy (FSHD) is a patchy and slowly progressive disease of skeletal muscle. MRI short tau inversion recovery (STIR) sequences of patient mu... | 104 kg. | Weight | CC BY | 33422031 | 18,990,465 | 2021-01-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukopenia'. | Heterogeneous constitutional mismatch repair deficiency with MSH6 missense mutation clinically benefits from pembrolizumab and regorafenib combination therapy: a case report and literature review.
BACKGROUND
Germline DNA mismatch repair (MMR) gene aberrations are associated with colorectal cancer (CRC) predisposition a... | CETUXIMAB, FLUOROURACIL, OXALIPLATIN | DrugsGivenReaction | CC BY | 33422121 | 19,065,655 | 2021-01-09 |
What was the dosage of drug 'CETUXIMAB'? | Heterogeneous constitutional mismatch repair deficiency with MSH6 missense mutation clinically benefits from pembrolizumab and regorafenib combination therapy: a case report and literature review.
BACKGROUND
Germline DNA mismatch repair (MMR) gene aberrations are associated with colorectal cancer (CRC) predisposition a... | 500 MG/KG Q14D; FOR 8 CYCLES | DrugDosageText | CC BY | 33422121 | 19,065,655 | 2021-01-09 |
What was the dosage of drug 'FLUOROURACIL'? | Heterogeneous constitutional mismatch repair deficiency with MSH6 missense mutation clinically benefits from pembrolizumab and regorafenib combination therapy: a case report and literature review.
BACKGROUND
Germline DNA mismatch repair (MMR) gene aberrations are associated with colorectal cancer (CRC) predisposition a... | FOR 8 CYCLES | DrugDosageText | CC BY | 33422121 | 19,065,655 | 2021-01-09 |
What was the dosage of drug 'OXALIPLATIN'? | Heterogeneous constitutional mismatch repair deficiency with MSH6 missense mutation clinically benefits from pembrolizumab and regorafenib combination therapy: a case report and literature review.
BACKGROUND
Germline DNA mismatch repair (MMR) gene aberrations are associated with colorectal cancer (CRC) predisposition a... | FOR 8 CYCLES | DrugDosageText | CC BY | 33422121 | 19,065,655 | 2021-01-09 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.